title: In vitro intestinal bioaccessibility of alkylglycerols versus triacylglycerols as vehicles of butyric acid.
abstract: Butyric acid has been the subject of much attention last years due to its bioactivity. However, the potential advantages of butyrate are limited by the problem to reach enough plasma concentrations; therefore, pro-drugs have been proposed as an alternative to natural butyrate. A comparative study on in vitro intestinal digestion of 2,3-dibutyroil-1-O-octadecyl glycerol (D-SCAKG) and tributyrin (TB), as potential pro-drugs of butyric acid, was performed. Aliquots were taken at different times of digestion for studying the extent and rate of hydrolysis of both substrates. The micellar phase (MP) and oily phase (OP) formed in the digestion media were separated and their composition in lipid products was analyzed. Initially, it was confirmed that the in vitro model reproduced physiological results by testing against olive oil as a standard lipid. The progress of in vitro intestinal digestion of D-SCAKG was slower than that of TB. TB hydrolyzed completely to butyric acid, whereas D-SCAKG mainly yielded 2-butyroil-1-O-octadecyl glycerol (M-SCAKG), followed by butyric acid and 1-O-octadecyl glycerol (AKG). The MP from both substrates mainly consisted of butyric acid. Minor levels of M-SCAKG and AKG were also found in the MP after hydrolysis of D-SCAKG, the M-SCAKG being mainly distributed in the OP. Therefore, D-SCAKG produced a stable form of esterified butyric acid as M-SCAKG after in vitro intestinal digestion, unlike TB. Additionally, such a product would integrate both bioactive compounds, butyric acid and alkylglycerol, within the same molecule. Free butyric acid and AKG would be also released, which are lipid products of interest as well.
authors.affiliation: Departamento de Producción y Caracterización de Nuevos Alimentos, Instituto de Investigación en Ciencias de la Alimentación (CIAL), Campus de la Universidad Autónoma de Madrid (CSIC-UAM), 28049, Cantoblanco, Madrid, Spain.
authors.forename: Diana
authors.initials: D
authors.lastname: Martín
authors.forename: María I
authors.initials: MI
authors.lastname: Morán-Valero
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Señoráns
authors.forename: Guillermo
authors.initials: G
authors.lastname: Reglero
authors.forename: Carlos F
authors.initials: CF
authors.lastname: Torres
mesh_terms: D001682:Biological Availability; D020148:Butyric Acid / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D004063:Digestion / Q000502:physiology; D004075:Diglycerides / Q000737:chemistry / Q000493:pharmacokinetics; D004339:Drug Compounding; D005990:Glycerol / Q000493:pharmacokinetics*; D005995:Glyceryl Ethers / Q000737:chemistry / Q000493:pharmacokinetics; D006801:Humans; D006868:Hydrolysis; D066298:In Vitro Techniques; D007413:Intestinal Mucosa / Q000378:metabolism*; D008954:Models, Biological; D014677:Pharmaceutical Vehicles / Q000493:pharmacokinetics*; D014280:Triglycerides / Q000737:chemistry / Q000493:pharmacokinetics*
chemical_list: C559209:2,3-dibutyroyl-1-O-octadecyl glycerol; D004075:Diglycerides; D005995:Glyceryl Ethers; D014677:Pharmaceutical Vehicles; D014280:Triglycerides; D020148:Butyric Acid; D005990:Glycerol; C005830:tributyrin